Small clinical trials have shown that one or two doses of psilocybin, given in a therapeutic setting, can make dramatic and long-lasting changes in people suffering from treatment-resistant major depressive disorder, which typically does not respond to traditional antidepressants.
Trending
- Excerpts from Russian opposition leader Navalny’s memoir show he knew he would die in prison
- What’s behind the northern lights that dazzled the sky farther south than normal
- It’s not just Fat Bear Week in Alaska. Trail cameras are also capturing wolves, moose and more
- Children and adults transported to a Pennsylvania hospital after ingesting ‘toxic mushrooms’
- As Hezbollah and Israel battle on the border, Lebanon’s army watches from the sidelines
- When Europe’s railroad dining cars were the height of luxury
- How psilocybin, the psychedelic in mushrooms, may rewire the brain to ease depression, anxiety and more
- Government spending on flights for Canadians fleeing the Middle East unpopular, Nanos survey finds